David Coghill
Overview
Explore the profile of David Coghill including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
208
Citations
6261
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Calderoni S, Coghill D
Front Child Adolesc Psychiatry
. 2025 Jan;
3:1372911.
PMID: 39839320
No abstract available.
2.
Stephens K, Sciberras E, Bisset M, Summerton A, Coghill D, Middeldorp C, et al.
J Atten Disord
. 2024 Dec;
29(5):303-311.
PMID: 39720846
Objectives: To determine ADHD research priorities from the perspective of ADHD professionals internationally. Method: A two-stage modified Delphi design was used. In Stage 1 (qualitative), participants listed research questions relating...
3.
4.
Carucci S, Di Martino A, Castellanos F, Masi G, Banaschewski T, Coghill D, et al.
J Child Adolesc Psychopharmacol
. 2024 Oct;
34(10):421-427.
PMID: 39403746
Professor Alessandro Zuddas, from the University of Cagliari (Italy), passed away prematurely in July 2022. As a prominent figure in child and adolescent neuropsychiatry, he substantially influenced the fields of...
5.
Schulze M, Coghill D, Lux S, Philipsen A, Silk T
Biol Psychiatry Cogn Neurosci Neuroimaging
. 2024 Sep;
PMID: 39218036
Background: Quantitative susceptibility mapping is a neuroimaging technique that detects local changes in magnetic susceptibility induced by brain iron. Brain iron and the dopaminergic system are linked because iron is...
6.
Cortese S, Coghill D, Fegert J, Mattingly G, Rohde L, Wong I, et al.
Eur Child Adolesc Psychiatry
. 2024 Aug;
34(1):369-371.
PMID: 39196420
No abstract available.
7.
Ferrin M, Hage A, Swanson J, Wong K, Dittmann R, Banaschewski T, et al.
Eur Child Adolesc Psychiatry
. 2024 Aug;
34(3):867-882.
PMID: 39105823
Low medication-adherence and persistence may reduce the effectiveness of ADHD-medication. This preregistered systematic review (PROSPERO CRD42020218654) on medication-adherence and persistence in children and adolescents with ADHD focuses on clinically relevant...
8.
Adamo N, Singh S, Bolte S, Coghill D, Newcorn J, Parlatini V, et al.
J Child Psychol Psychiatry
. 2024 Jul;
65(11):1526-1537.
PMID: 39014993
Many youths with attention-deficit/hyperactivity disorder (ADHD) experience significant long-term impairment and may develop concurrent mental and somatic health difficulties as adults. This is associated with burden and costs for the...
9.
Mulraney M, de Silva U, Joseph A, Sousa Fialho M, Dutia I, Munro N, et al.
JAMA Netw Open
. 2024 Jun;
7(6):e2416760.
PMID: 38869906
Importance: The use of evidence-based standardized outcome measures is increasingly recognized as key to guiding clinical decision-making in mental health. Implementation of these measures into clinical practice has been hampered...
10.
Bellato A, Perrott N, Marzulli L, Parlatini V, Coghill D, Cortese S
J Am Acad Child Adolesc Psychiatry
. 2024 Jun;
64(3):346-361.
PMID: 38823477
Objective: We conducted a systematic review and meta-analysis to quantify the effect of attention-deficit/hyperactivity disorder (ADHD) medication on quality of life (QoL), and to understand whether this effect differs between...